|
|
More United States Rheumatology/Arthritis reports
MediPoint: Total Wrist Reconstruction - US Analysis and Market Forecasts by GlobalData
MediPoint: Total Wrist Reconstruction - US Analysis and Market ForecastsSummaryInjuries to any of the bones, ligaments, tendons or nerves in the wrist joint can cause ...
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven Update by GlobalData
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven UpdateSummaryGlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - United States ...
TreatmentTrends®: Rheumatoid Arthritis US (Wave 3) 2012 by Decision Resources
TreatmentTrends® Biologics in Rheumatoid Arthritis is a report that covers the use of biologics for the treatment of RA. The report, part of a quarterly ...
ChartTrends®: Rheumatoid Arthritis (US) 2012 by Decision Resources
See all reports like this >>This report is an annual publication that provides comprehensive insight into the management of rheumatoid arthritis (RA) patients being treated with biologics based on actual ...
More United States reports
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
See all reports like this >>D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
- Diseases & Conditions
- Arthritis
- Pharmaceuticals
- Prescription Drugs
- Therapeutic Area
- Rheumatology/Arthritis
Rheumatology/Arthritis Reports
- Rheumatoid Arthritis – Pipeline Review, H1 2013
- Rheumatoid Arthritis Partnering 2007-2013
- Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth
- Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
- LaunchTrends®: Abatacept SC (Orencia SC) (Wave 4) 2012
